Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the Phase 1 clinical trial of AMX0114, ...

The FDA has granted approval for Zydus to proceed with the Phase II(b) trial of Usnoflast for amyotrophic lateral sclerosis (ALS) treatment.

Famed Saw filmmaker Leigh Whannell has revealed that the late Australian actor Heath Ledger helped to inspire a crucial detail in his new Wolf Man movie.

CAMBRIDGE, Mass. - Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX), a $245.1 million market cap biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical ...

Exercise not only benefits physical health but also stimulates neuronal growth, paving the way for innovative nerve repair ...

The former Bison player was diagnosed with the disease at age 34. He has reunited with a former teammate, coach John Griffin ...

With the hold lifted, Amylyx can begin screening and enrolling for its Phase 1 LUMINA trial, which will test AMX0114 in ALS ...

Brain-computer interfaces translate neural signals into actions, revolutionizing healthcare and enhancing communication for individuals with disabilities.

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...